{
    "2020-09-28": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|外包】节后普涨，一体化整合是外包发展的重要选择",
                "features": {
                    "keywords": [
                        "外包",
                        "节后普涨",
                        "一体化整合"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：拟投资3亿元设立子公司",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "投资",
                        "子公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821.SZ)：与镇江经开区管委会签署小分子药物综合性研发生产基地项目投资协议 预计投资总额40-50亿元",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "镇江",
                        "小分子药物",
                        "研发生产",
                        "投资协议"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：拟以40-50亿元在镇江市投资小分子药物综合性研发生产基地",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "镇江",
                        "小分子药物",
                        "研发生产",
                        "投资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：拟40亿-50亿元投建小分子药物综合性研发生产基地项目",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "小分子药物",
                        "研发生产",
                        "投资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821.SZ)：拟出资3亿元在镇江设立全资子公司主营小分子CDMO化学原料及原料药研发生产",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "镇江",
                        "全资子公司",
                        "小分子CDMO",
                        "研发生产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：海外疫情反复 关注三季报业绩预期突出板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "海外疫情",
                        "三季报",
                        "业绩预期"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}